Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores.

IF 2.6 1区 医学
Umberto Pensato, Koji Tanaka, Chitapa Kaveeta, Johanna Ospel, MacKenzie Horn, David Rodriguez-Luna, Nishita Singh, Ankur Banerjee, Sanchea Wasyliw, Kennedy Horn, Amy Bobyn, Anneliese Neweduk, Wu Qiu, Mayank Goyal, Bijoy Menon, Andrew Demchuk
{"title":"Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores.","authors":"Umberto Pensato, Koji Tanaka, Chitapa Kaveeta, Johanna Ospel, MacKenzie Horn, David Rodriguez-Luna, Nishita Singh, Ankur Banerjee, Sanchea Wasyliw, Kennedy Horn, Amy Bobyn, Anneliese Neweduk, Wu Qiu, Mayank Goyal, Bijoy Menon, Andrew Demchuk","doi":"10.1136/svn-2024-003988","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We aim to comprehensively assess and compare the predictive performance of haematoma expansion (HE) scores in a homogeneous cohort of acute intracerebral haemorrhage (ICH) patients.</p><p><strong>Methods: </strong>Existing scores for predicting HE in acute ICH patients were included and categorised by imaging modality: non-contrast CT (NCCT), single-phase CT angiography (sCTA) and multiphase CTA (mCTA). The predictive performance of the scores was evaluated with the c-statistic in a population of consecutive adult patients with acute ICH admitted to a tertiary care centre in Southern Alberta, Canada, between February 2012 and May 2020, investigated with a multimodal imaging protocol (NCCT, sCTA and mCTA). The primary outcome was HE (ICH volume growth ≥6 mL or ≥33%), and the secondary outcome was severe HE (ICH volume growth ≥12.5 mL or ≥66%). The DeLong test compared the best-performing scores from each imaging category.</p><p><strong>Results: </strong>16 HE scores were assessed (NCCT=8, sCTA=6 and mCTA=2) in 217 patients with a median age of 70 years (IQR=60-80), and 86 (39.6%) were females. 51 (23.5%) patients experienced HE and 35 (16.1%) had severe HE. The c-statistic for predicting HE ranged from 0.516 to 0.674 for NCCT-based scores, 0.627 to 0.725 for sCTA-based scores and 0.800 to 0.814 for mCTA-based score. The c-statistic for predicting severe HE ranged from 0.505 to 0.666 for NCCT scores, 0.651 to 0.740 for sCTA scores and 0.813 to 0.828 for mCTA scores. A statistically significant difference favouring mCTA over other imaging modalities in predicting both HE and severe HE was observed.</p><p><strong>Conclusions: </strong>Advanced imaging demonstrated a stepwise improvement in the predictive performance of HE scores. However, no existing score achieved excellent predictive performance (c-statistics ≥0.90) in our cohort, highlighting the need for further refinement.</p>","PeriodicalId":48733,"journal":{"name":"Journal of Investigative Medicine","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Investigative Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/svn-2024-003988","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We aim to comprehensively assess and compare the predictive performance of haematoma expansion (HE) scores in a homogeneous cohort of acute intracerebral haemorrhage (ICH) patients.

Methods: Existing scores for predicting HE in acute ICH patients were included and categorised by imaging modality: non-contrast CT (NCCT), single-phase CT angiography (sCTA) and multiphase CTA (mCTA). The predictive performance of the scores was evaluated with the c-statistic in a population of consecutive adult patients with acute ICH admitted to a tertiary care centre in Southern Alberta, Canada, between February 2012 and May 2020, investigated with a multimodal imaging protocol (NCCT, sCTA and mCTA). The primary outcome was HE (ICH volume growth ≥6 mL or ≥33%), and the secondary outcome was severe HE (ICH volume growth ≥12.5 mL or ≥66%). The DeLong test compared the best-performing scores from each imaging category.

Results: 16 HE scores were assessed (NCCT=8, sCTA=6 and mCTA=2) in 217 patients with a median age of 70 years (IQR=60-80), and 86 (39.6%) were females. 51 (23.5%) patients experienced HE and 35 (16.1%) had severe HE. The c-statistic for predicting HE ranged from 0.516 to 0.674 for NCCT-based scores, 0.627 to 0.725 for sCTA-based scores and 0.800 to 0.814 for mCTA-based score. The c-statistic for predicting severe HE ranged from 0.505 to 0.666 for NCCT scores, 0.651 to 0.740 for sCTA scores and 0.813 to 0.828 for mCTA scores. A statistically significant difference favouring mCTA over other imaging modalities in predicting both HE and severe HE was observed.

Conclusions: Advanced imaging demonstrated a stepwise improvement in the predictive performance of HE scores. However, no existing score achieved excellent predictive performance (c-statistics ≥0.90) in our cohort, highlighting the need for further refinement.

先进影像学对脑内血肿扩张预测的逐步改善:现有评分的综合比较。
背景:我们的目的是全面评估和比较急性脑出血(ICH)患者同质队列中血肿扩张(HE)评分的预测性能。方法:纳入预测急性脑出血患者HE的现有评分,并根据成像方式进行分类:非对比CT (NCCT)、单期CT血管造影(sCTA)和多期CTA (mCTA)。在2012年2月至2020年5月期间,在加拿大南阿尔伯塔省一家三级医疗中心住院的连续成年急性脑出血患者人群中,采用多模式成像方案(NCCT、sCTA和mCTA)对评分的预测性能进行了c统计评估。主要结局为HE(脑出血体积增长≥6ml或≥33%),次要结局为重度HE(脑出血体积增长≥12.5 mL或≥66%)。DeLong测试比较了每个成像类别中表现最好的分数。结果:217例患者的HE评分为16分(NCCT=8, sCTA=6, mCTA=2),中位年龄为70岁(IQR=60-80),其中86例为女性(39.6%)。51例(23.5%)为HE, 35例(16.1%)为重度HE。ncct评分预测HE的c统计量为0.516 ~ 0.674,scta评分预测HE的c统计量为0.627 ~ 0.725,mcta评分预测HE的c统计量为0.800 ~ 0.814。NCCT评分预测严重HE的c统计量为0.505 ~ 0.666,sCTA评分为0.651 ~ 0.740,mCTA评分为0.813 ~ 0.828。与其他成像方式相比,mCTA在预测HE和严重HE方面具有统计学上的显著差异。结论:先进的影像学显示了HE评分预测性能的逐步改善。然而,在我们的队列中,没有现有评分达到出色的预测性能(c-statistics≥0.90),这表明需要进一步改进。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Investigative Medicine
Journal of Investigative Medicine MEDICINE, GENERAL & INTERNALMEDICINE, RESE-MEDICINE, RESEARCH & EXPERIMENTAL
自引率
0.00%
发文量
111
期刊介绍: Journal of Investigative Medicine (JIM) is the official publication of the American Federation for Medical Research. The journal is peer-reviewed and publishes high-quality original articles and reviews in the areas of basic, clinical, and translational medical research. JIM publishes on all topics and specialty areas that are critical to the conduct of the entire spectrum of biomedical research: from the translation of clinical observations at the bedside, to basic and animal research to clinical research and the implementation of innovative medical care.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信